Search Tag: gadolinium

IT Management

Deep-learning-reduces-need-for-gadolinium-contrast

2021 26 Oct

Gadolinium-based contrast agents (GBCAs), used during MRI scans, enhance brain tissue contrast. GBCAs are crucial for brain tumour care because they highlight areas with abnormal blood-brain barrier permeability that tumours cause.  This permits monitoring of treatment response and also guide surgical tumour removal.  Disadvantages to using GBCAs include...Read more

IMAGING Management

Future-of-ultrasound-ed-gamification-vr

2019 13 Feb

Executive Summary Prof. Paul Sidhu , President of the European Federation of Societies for Ultrasound in Medicine and Biology ( EFSUMB ), shares with Healthmanagement.org a preview of his presentations at the forthcoming ECR 2019 .  The use of ultrasound simulation models as tools in training and education is among the important...Read more

IMAGING Management

Sectra-offers-radiology-an-easy-way-to-improve-gadolinium-tracking

2017 27 Nov

International medical imaging IT and cybersecurity company Sectra is globally introducing gadolinium tracking in its dose monitoring solution, Sectra DoseTrack. Gadolinium is a contrast agent commonly used to enhance images during MRI exams. By systematically registering gadolinium information, healthcare providers can reduce the risk of patients...Read more

IMAGING Management

Parkinsonism-risk-from-gadolinium-enhanced-mris-insignificant

2016 05 Jul

A study of about 247,000 elderly patients who were subject to gadolinium-enhanced MRIs has shown that there was no significant association between exposure to the contrast agent and parkinsonism. The study was conducted because of growing safety concerns over retained gadolinium in the globus pallidi (an area of the brain), whereas neurotoxic...Read more

IMAGING Management

Ecr2016-gadolinium-contrast-agent-safety-facts-and-myths

2016 05 Mar

Over the past 25 years, gadolinium-based contrast agents (GBCA) have been recognised to have exceptional safety profiles with minimal side effects, as three researchers showed in their presentations at the European Congress of Radiology (ECR 2016) in Vienna. Dr. Richard Semelka of the Department of Radiology, University of North Carolina...Read more

IMAGING Management

Mri-contrast-agents-study-highlights-safety-issue

2015 28 Jun

A new study, published in the journal Investigative Radiology , indicates that repeated use of specific “linear”-type gadolinium-based contrast agents (GBCAs) — widely used for diagnostic MRI scans — can lead to deposits of the heavy-metal element gadolinium in the brain. The findings could have a major impact on the multimillion-dollar market for...Read more